Transition Therapeutics, Inc. (TTHI) Reports Q2 Loss of $0.15, Had No Revenue

Transition Therapeutics, Inc. (NASDAQ: TTHI) reported Q2 EPS of ($0.15), versus $0.22 reported last year. Revenue for the quarter came in at $0 , versus $9.4 million reported last year.

For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Wolverine World Wide (WWW) PT Raised to $26 at Stifel as Multiple Can Move Higher